#EBW25 Editorial: Advancing clinical research and diagnostics with Bruker’s cutting-edge innovations
This article has 409 words and is a 2-minute read.
The Europe Biobank Week Congress highlights the latest innovations and key themes within the global biobanking and biomolecular resources community. It serves as a central platform for professionals, patients, and government representatives to connect, exchange knowledge, and gain valuable insights. Over four days, attendees enjoy inspiring keynote talks, engaging discussions, networking opportunities, and exhibits featuring the latest technologies and products.
We have spoken with each of our 2025 sponsors to understand why they value participating in the most important in-person event of the year for the global biobanking community. This is what Bruker shared with us.
Company description
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.
Today, worldwide more than 9700 employees are working on this permanent challenge at over 90 locations on all continents. Bruker continues to build upon its extensive range of products and solutions, its broad base of installed systems and a strong reputation among its customers. Being one of the world’s leading analytical instrumentation companies, Bruker is strongly committed to further fully meet its customers’ needs as well as to continue to develop state-of-the-art technologies and innovative solutions for today’s analytical questions.
Why does it matter to be at EBW25?
Being at EBW25 is crucial for Bruker as it provides a unique platform to connect with leading experts in the biobanking and clinical research fields. This event allows us to showcase our latest innovations, engage in meaningful collaborations, and stay at the forefront of advancements that drive the future of healthcare and diagnostics.
What new innovation are you bringing or what are you most looking forward to?
At EBW25, Bruker is excited to introduce our latest advancements in clinical phenomics and proteomics. Our cutting-edge diagnostic solutions are designed to enhance the precision and efficiency of clinical research, ultimately improving patient outcomes. We look forward to demonstrating how our technologies can revolutionise the way biobanks operate and contribute to groundbreaking discoveries in human health.